Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice
Tóm tắt
A West Nile virus (WNV) infection in humans can produce neurological symptoms including acute flaccid paralysis, encephalitis, meningitis and myelitis. To investigate the pathogenesis of WNV in the peripheral and the central nervous system (PNS and CNS), the authors used a murine footpad inoculation model of WNV infection. Survival curves of virus-infected animals of ages 4- to 6-weeks-old demonstrated age-dependent mortality where older animals (6-weeks-old) had a higher mortality rate compared to younger animals (4- and 5-weeks-old). The mice that survived the virus infection formed WNV-reactive antibodies, confirming viral infection and clearance. The localization of viral RNA (vRNA) and antigen in infected murine tissues was investigated using TaqMan and immunohistochemistry (IHC) respectively. During a nine day infection, vRNA levels in the spinal cord and brainstem fluctuated, suggesting early viral clearance from these tissues by days 3–4 p.i. with later re-introduction. Viral antigens detected using IHC were primarily observed in three main regions of the brain: cortex, hippocampus and brainstem. Additionally, the dorsal root ganglion neurons of the PNS stained positive for viral antigens. These data are consistent with multiple routes of neuroinvasion following a peripheral inoculation of virus and do not preclude the previous observation that virus-infected peripheral neurons can introduce virus into the CNS by a retrograde transport mechanism.
Tài liệu tham khảo
Beasley DW, Li L, Suderman MT, Barrett AD (2002). Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 296: 17–23.
Biggerstaff BJ, Petersen LR (2002). Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 42: 1019–1026.
Brinton MA (2002). The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu Rev Microbiol 56: 371–402.
CDC (1999). Update: West Nile Virus encephalitis—New York, 1999. MMWR 48: 944–964.
Diamond MS, Shrestha B, Marri A, Mahan D, Engle M (2003a). B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77: 2578–2586.
Diamond MS, Shrestha B, Mehlhop E, Sitati E, Engle M (2003b). Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol 16: 259–278.
Doron SI, Dashe JF, Adelman LS, Brown WF, Werner BG, Hadley S (2003). Histopathologically proven poliomyelitis with quadriplegia and loss of brainstem function due to West Nile virus infection. Clin Infect Dis 37: e74–77.
Franklin KB, Paxinos G (1977). The Mouse Brain in stereotaxic coordinates. Academic Press: San Diego.
Fratkin JD, Leis AA, Stokic DS, Slavinski SA, Geiss RW (2004). Spinal cord neuropathology in human West Nile virus infection. Arch PatholLab Med 128: 533–537.
Griffin DE (2003). Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol 3: 493–502.
Haahr S (1968). The occurrence of virus and interferon in the spleen, serum and brain in mice after experimental infection with West Nile virus. Acta Pathol Microbiol Scand 74: 445–457.
Hoffman WH, Haberly LB (1991). Bursting-induced epileptiform EPSPs in slices of piriform cortex are generated by deep cells. J Neurosci 11: 2021–2031.
Hunsperger E, Roehrig JT (2005). Characterization of West Nile viral replication and maturation in peripheral neurons in culture. J of NeuroVirol 11: 11–22.
Klee AL, Maidin B, Edwin B, Poshni I, Mostashari F, Fine A, Layton M, Nash D (2004). Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 10: 1405–1411.
Lanciotti RS, Ebel GD, Deubel V, Kerst AJ, Murri S, Meyer R, Bowen M, McKinney N, Morrill WE, Crabtree MB, Kramer LD, Roehrig JT (2002). Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 298: 96–105.
Lanciotti RS, Kerst AJ, Nasci RS, Godsey MS, Mitchell CJ, Savage HM, Komar N, Panella NA, Allen BC, Volpe KE, Davis BS, Roehrig JT (2000). Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 38: 4066–4071.
Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele K, Crise B, Volpe KE, Crabtree MB, Scherret JH, Hall RA, MacKenzie JS, Cropp CB, Panigrahy B, Ostlund E, Schmitt B, Malkinson M, Banet C, Weissman J, Komar N, Savage HM, Stone W, McNamara T, Gubler DJ (1999). Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286: 2333–2337.
Leis AA, Fratkin J, Stokic DS, Harrington T, Webb RM, Slavinski SA (2003). West Nile poliomyelitis. Lancet Infect Dis 3: 9–10.
Monath TP, Cropp CB, Harrison AK (1983). Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Invest 48: 399–410.
Nathanson N (1980). Pathogenesis. In: St Louis Encephalitis. Monath TP (ed). American Public Health Association: Washington, DC, pp 201–236.
Nathanson N, Cole GA (1971). Immunosuppression: a means to assess the role of the immune response in acute virus infections. Fed Proc 30: 1822–1830.
Roehrig JT, Nash D, Maldin B, Labowitz A, Martin DA, Lanciotti RS, Campbell GL (2003). Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases. Emerg Infect Dis 9: 376–379.
Sampson BA, Armbrustmacher V (2001). West Nile encephalitis: the neuropathology of four fatalities. Ann NY Acad Sci 951: 172–178.
Sejvar JJ, Leis AA, Stokic DS, Van Gerpen JA, Marfin AA, Webb R, Haddad MB, Tierney BC, Slavinski SA, Polk JL, Dostrow V, Winkelmann M, Petersen LR (2003). Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 9: 788–793.
Shrestha B, Diamond MS (2004). Role of CD8+ T cells in control of West Nile virus infection. J Virol 78: 8312–8321.
Shrestha B, Gottlieb D, Diamond MS (2003). Infection and injury of neurons by West Nile encephalitis virus. J Virol 77: 13203–13213.
Smith RD, Konoplev S, De Courten-Myers G, Brown T (2004). West Nile virus encephalitis with myositis and orchitis. Hum Pathol 35: 254–258.
Smithburn K, Hughes T, Burke A (1940). A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 20: 471–492.
Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA (2004). Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10: 1366–1373.